During the past decade, Centre Hospitalier de Beauvais conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de Beauvais" #1 sponsor was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 14 trials, followed by "Federation Francophone de Cancerologie Digestive" with 11 trials sponsored, "UNICANCER" with 10 trials sponsored, "Centre Hospitalier Universitaire, Amiens" with 9 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 9 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Beauvais" #1 collaborator was "Ministry of Health, France" with 3 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator, "Groupe Francais De Pneumo-Cancerologie" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator and "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Beauvais" are "Colorectal Cancer" (7 trials), "Lung Cancer" (5 trials), "Pancreatic Cancer" (5 trials), "Breast Cancer" (4 trials) and "Metastatic Colorectal Cancer" (4 trials). Many other conditions were trialed in "Centre Hospitalier de Beauvais" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de Beauvais" are "Drug" (50 trials), "Procedure" (14 trials), "Other" (12 trials), "Radiation" (9 trials) and "Device" (6 trials). Other intervention types were less common.

The name of intervention was led by "gemcitabine hydrochloride" (8 trials), "radiation therapy" (6 trials), "fluorouracil" (5 trials), "Bevacizumab" (4 trials) and "adjuvant therapy" (4 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de Beauvais" are 75 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier de Beauvais". 1 are not yet recruiting, 15 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Centre Hospitalier de Beauvais, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de Beauvais, 0 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".

Centre Hospitalier de Beauvais has several departments that took part in Clinical trials: "Centre Hospitalier; Hematologie-Oncologie" - 3 trials, "Service de Pneumologie" - 3 trials